CASTRATION-RESISTANT PROSTATE CANCER
Clinical trials for CASTRATION-RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATION-RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for CASTRATION-RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for Tough-to-Treat prostate cancer
Disease control Recruiting nowThis study is testing whether adding an experimental drug called carotuximab to an existing prostate cancer drug (apalutamide) can better control advanced prostate cancer that has stopped responding to standard hormone treatments. The trial will involve about 100 men whose cancer…
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: Edwin Posadas, MD • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Radioactive 'Smart Bomb' tested for tough prostate cancer
Disease control Recruiting nowThis study is testing a new radioactive drug called 161Tb-RAD402 for men with advanced prostate cancer that has stopped responding to standard hormone treatments. The drug is designed to seek out and deliver radiation directly to prostate cancer cells. The study will first find t…
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Radiopharm Theranostics, Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Mayo clinic tests if less treatment works just as well for prostate cancer
Disease control Recruiting nowThis study is testing whether less aggressive treatment works as well as more intensive therapy for prostate cancer that has returned or spread. Researchers are comparing different approaches, including targeted radiation alone versus radiation combined with hormone-blocking drug…
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New Plant-Based combo targets tough prostate cancer
Disease control Recruiting nowThis early-stage study is testing whether an oral medication called GZ17-6.02 can slow the progression of advanced prostate cancer that has become resistant to standard hormone-blocking drugs. The trial will enroll about 30 men whose cancer has worsened despite prior treatments. …
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE1 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
First patients to try new pill targeting advanced cancers
Disease control Recruiting nowThis is the first study in people for a new oral drug called DCC-2812. It aims to find a safe dose and see if it can help control advanced kidney, bladder, or prostate cancer that has spread. The study will enroll about 60 people to check for side effects and see if the drug show…
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE1 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
New drug combo tested for Tough-to-Treat prostate cancer
Disease control Recruiting nowThis study is testing whether a combination of two drugs, cabozantinib and nivolumab, can help control advanced prostate cancer that has spread and no longer responds to standard hormone treatments. It will involve about 47 men who have already tried other therapies. The main goa…
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: Rana McKay, MD • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC
-
Timing is everything: study aims to perfect prostate cancer scan schedule
Knowledge-focused Recruiting nowThis study aims to understand how hormone therapy changes what doctors see on a special prostate cancer scan (PSMA PET). Researchers will track 80 men with prostate cancer, taking scans before treatment and again 8 and 28 days after starting hormone therapy. The goal is to learn …
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE4 • Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Blood test could reveal best prostate cancer drug before treatment starts
Knowledge-focused Recruiting nowThis study aims to see if a simple blood test can predict which hormone therapies will work for men with advanced prostate cancer that has spread. Researchers will follow 120 men receiving standard treatment, checking their blood for cancer cells to look for genetic clues linked …
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Mar 10, 2026 12:53 UTC